He was appointed to the Australian Cancer Research Foundation Medical Research Advisory Committee (MRAC) in 1997, and served as Chair of the Foundation for five years before stepping down in 2007. He currently serves on the Board of Governors of the Centenary Institute, the Sydney Institutes of Health and Medical Research and the Arts & Health Foundation.
As a qualified physician (FRACP) and pathologist in immunology (FRCPA) and has practiced as such in Sydney, Melbourne and Adelaide, as well as in Boston MA, USA. His research has primarily focused on understanding the inflammatory pathway as it contributes to chronic diseases and cancer. With special emphasis on endothelial biology he uses a multidisciplinary approach to discover new molecules that may uncover fundamental phenomena of nature and lead to novel therapeutics.
An inventor on more than 30 patents and having published over 280 high impact papers primarily in the area of inflammation, Professor Vadas is a leader in the field. His highly original and medically relevant work has been cited over 17,000 times, and has been recently recognised as an Inaugural Citation Laureate in Australia – one of five in this discipline.
Under his stewardship the Centenary Institute has grown rapidly and has strengthened its links with Sydney University, Royal Prince Alfred Hospital and more recently with LIfehouse, with the formation of Centenary-Lifehouse Cancer Research Centre. In the past he was the primary initiator and Inaugural Director of the Hanson Centre for Cancer Research (now Hanson Institute), and has contributed strongly to the Australian biotechnology sector, being involved in the establishment of two ASX listed biotechnology companies.
Professor Vadas has enjoyed strong support for his research, including being Chief Investigator on a Program Grant from the National Health & Medical Research Council since 1993.
See the links below for more information or further reading on Professor Mathew A. Vadas and his work: